Liminatus Pharma Says Common Stock Transferred To Nasdaq Capital Market Effective August 4; Nasdaq Panel Grants Extension Until September 3 To Regain Minimum Bid Price Compliance
Share
Why It Matters
A medicine company's stock moved to a smaller trading floor because its share price got too low. The company has until early September to bring the price back up, or it could face bigger problems.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.